Deadline Date: May 31, 2026
The DayOne Accelerator is seeking applications to accelerate their growth by developing innovative solutions at the intersection of healthtech and pharmaceutical research and development.
The programme focuses on healthtech and techbio solutions enabling pharma R&D, including AI-aided drug discovery, digital or imaging biomarkers, diagnostics, clinical trial protocol optimization, patient screening and stratification, and decentralized clinical trials with remote monitoring, while also emphasizing value proposition development, industry collaboration, and accelerated business growth.
To support participation, ventures may receive up to CHF 1,000 to cover part of their travel and accommodation costs for the initial bootcamp, depending on their country of origin and at the discretion of Basel Area Business & Innovation.
The DayOne Accelerator is a three-month hybrid programme based in Basel, Switzerland, recognized as a leading life sciences innovation hub in Europe. It is designed to support high-potential international startups in refining their value proposition, connecting with key industry players, and advancing their growth within the pharma ecosystem.
The programme targets founders and teams operating in healthtech and techbio who are aiming to collaborate or partner with pharmaceutical companies. It is open to startups at the pre-seed to Series A stage that have raised less than 10 million USD in dilutive funding. Individuals and teams from any country are eligible to apply, whether or not they have formally registered a company.
Participants benefit from direct access to pharma industry experts and key players in the Basel area, along with hands-on mentorship to refine their pharma-specific value proposition. The programme also provides exposure to Basel’s life sciences ecosystem, offering opportunities to engage with global pharmaceutical leaders.
Selected startups may gain access to additional post-accelerator support, including non-dilutive funding of up to CHF 50,000, personalized support of equal value, and up to 12 months of office space. The accelerator itself is equity-free and fee-free, allowing participants to maintain independence while scaling their ventures.
For more information, visit Basel Area Business & Innovation.
